NE LB109

Prohibits insurers and pharmacy benefit managers (PBMs) from refusing to pay participating providers for covered clinician-administered drugs, imposing higher copays or penalties when patients obtain these drugs from authorized providers, or steering patients away from their chosen provider through financial incentives

Bars insurers from requiring clinician-administered drugs to be dispensed only by insurer-selected pharmacies, reducing reimbursement based on drug source, or requiring patients to transport medications from specialty pharmacies to providers for administration

Defines clinician-administered drugs as outpatient prescription drugs (excluding vaccines) that cannot reasonably be self-administered and are typically given by health care providers in physician offices, hospital outpatient centers, pharmacies, or clinical settings

Prohibits PBMs from restricting how retail community pharmacies dispense or deliver prescriptions, including shipping or mailing to patient-requested locations, and bars requiring pharmacies to participate in mail-order contracts

Requires PBMs to allow Nebraska pharmacies with nationally recognized specialty accreditation into specialty pharmacy networks if they accept "reasonable" terms, which cannot exceed accreditation requirements or include excessive or punitive fees